Dental care to patients using Biposphonates: Case report
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/18103 |
Resumo: | Osteoporosis is a progressive systemic disease of the skeleton, characterized by reduced bone density and microstructure deterioration of bone tissue. For treatment, the use of bisphosphonates (BFFs) has been recommended as the first choice anti-resorptive therapy. The objective of this work is to describe, through a case report, a dental care protocol for a patient with Osteoporosis and using BFs. The work was submitted and approved by the Research Ethics Committee (CEP), opinion No.: 3.646.508/2019. Female patient, 30 years old, black, with osteoporosis, was referred for dental treatment. At the time of the Anamnesis, he reported using Alendronate Sodium 70mg/day. After clinical examination, laboratory tests for CTX-I dosage and radiographic evaluation, the suggested treatment plan was presented: clinical crown augmentation surgery and subsequent endodontic treatment and oral rehabilitation of tooth 25, which was promptly approved by the patient and signed the Informed Consent Term (TCLE). One week before the surgical procedure for clinical crown augmentation, the suspension of Alendronate sodium was requested. After the endodontic treatment, the prosthetic rehabilitation was carried out, restoring the masticatory and aesthetic function of the teeth, restoring the patient's self-esteem. It was concluded in the present study that it is possible to carry out the dental treatment of patients in bisphosphonate therapy safely, if a well-conducted and detailed anamnesis is carried out and safe treatment protocols are adopted, always aiming at the quality of life and patient satisfaction. |
id |
UNIFEI_f5cee07413dbcbe06a41c022da64cdf7 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/18103 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Dental care to patients using Biposphonates: Case reportAtención Dental al paciente con Biposfonatos: Reporte de casoAtendimento Odontológico a paciente em uso de Bifosfonatos: Relato de casoOsteoporoseBifosfonatosOsteonecroseOdontólogos.OsteoporosisDiphosphonatesOsteonecrosisDentists.OsteoporosisBifosfonatosOsteonecrosisOdontologos.Osteoporosis is a progressive systemic disease of the skeleton, characterized by reduced bone density and microstructure deterioration of bone tissue. For treatment, the use of bisphosphonates (BFFs) has been recommended as the first choice anti-resorptive therapy. The objective of this work is to describe, through a case report, a dental care protocol for a patient with Osteoporosis and using BFs. The work was submitted and approved by the Research Ethics Committee (CEP), opinion No.: 3.646.508/2019. Female patient, 30 years old, black, with osteoporosis, was referred for dental treatment. At the time of the Anamnesis, he reported using Alendronate Sodium 70mg/day. After clinical examination, laboratory tests for CTX-I dosage and radiographic evaluation, the suggested treatment plan was presented: clinical crown augmentation surgery and subsequent endodontic treatment and oral rehabilitation of tooth 25, which was promptly approved by the patient and signed the Informed Consent Term (TCLE). One week before the surgical procedure for clinical crown augmentation, the suspension of Alendronate sodium was requested. After the endodontic treatment, the prosthetic rehabilitation was carried out, restoring the masticatory and aesthetic function of the teeth, restoring the patient's self-esteem. It was concluded in the present study that it is possible to carry out the dental treatment of patients in bisphosphonate therapy safely, if a well-conducted and detailed anamnesis is carried out and safe treatment protocols are adopted, always aiming at the quality of life and patient satisfaction.La osteoporosis es una enfermedad sistémica progresiva del esqueleto, caracterizada por la reducción de la densidad ósea y el deterioro de la microestructura del tejido óseo. Para el tratamiento, se ha recomendado el uso de bisfosfonatos (BF) como la terapia antirresortiva de primera elección. El objetivo de este trabajo es describir, a través de un caso clínico, un protocolo de atención odontológica para un paciente con Osteoporosis y utilizando BFF. El trabajo fue presentado y aprobado por el Comité de Ética en Investigación (CEP), opinión No: 3.646.508 / 2019. Paciente mujer de 30 años, negra, con osteoporosis, remitida para tratamiento odontológico. En el momento de la anamnesis, informó haber usado alendronato sódico 70 mg / día. Después del examen clínico, las pruebas de laboratorio para la dosificación de CTX-I y la evaluación radiográfica, se presentó el plan de tratamiento sugerido: cirugía clínica de aumento de corona y posterior tratamiento endodóntico y rehabilitación oral del diente 25, que fue aprobado de inmediato por el paciente y firmado el Término de consentimiento informado (TCLE). Una semana antes del procedimiento quirúrgico de aumento clínico de corona, se solicitó la suspensión de alendronato sódico. Tras el tratamiento de endodoncia, se realizó la rehabilitación protésica, restableciendo la función masticatoria y estética de los dientes, devolviendo la autoestima del paciente. Se concluyó en el presente estudio que es posible realizar el tratamiento odontológico de los pacientes en terapia con bisfosfonatos de manera segura, siempre que se realice una anamnesis bien realizada y detallada y se adopten protocolos de tratamiento seguros, siempre con el objetivo de la calidad de vida y satisfacción del paciente.A osteoporose é uma doença sistêmica progressiva do esqueleto, caracterizada pela redução da densidade óssea e deterioração microestrutura do tecido ósseo. Para o tratamento, tem sido preconizado como terapia antirreabsortiva de 1ª escolha, o uso de Bifosfonatos (BFs). O objetivo deste trabalho é descrever por meio de relato de caso, protocolo de atendimento odontológico a paciente portador de Osteoporose e em uso de BFFs. O trabalho foi submetido e aprovado pelo Comitê de Ética em Pesquisa (CEP), parecer n°: 3.646.508/2019. Paciente gênero feminino, 30 anos, melanoderma, portadora de Osteoporose, foi encaminhada para realização de tratamento odontológico. No momento da Anamnese relatou fazer uso de Alendronato de Sódio 70mg/dia. Após o exame clínico, exames laboratoriais para dosagem de CTX-I e avaliação radiográfica, apresentou- se o plano de tratamento sugerido: cirurgia de aumento de coroa clínica e posterior tratamento endodôntico e reabilitação oral do dente 25, que foi prontamente aprovado pela paciente e assinado o Termo de Consentimento Livre e Esclarecido (TCLE). Uma semana antes da realização do procedimento cirúrgico de aumento de coroa clínica, foi solicitado a suspensão do Alendronato de sódio. Após o tratamento endodôntico, foi feita a reabilitação protética, restituindo a função mastigatória e estética dos dentes, devolvendo a autoestima à paciente. Concluiu-se no presente estudo que é possível realizar o tratamento odontológico do paciente em terapia com Bifosfonatos com segurança, desde que realizada anamnese bem conduzida e detalhada e adotados protocolos seguros de tratamento, sempre visando a qualidade de vida e satisfação do paciente.Research, Society and Development2021-07-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1810310.33448/rsd-v10i9.18103Research, Society and Development; Vol. 10 No. 9; e22810918103Research, Society and Development; Vol. 10 Núm. 9; e22810918103Research, Society and Development; v. 10 n. 9; e228109181032525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/18103/16084Copyright (c) 2021 Elizama de Lima Amazonas; Darcleia Souza Sacht; Ranniely de Souza Alves; Nely Cristina Medeiros Caireshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAmazonas, Elizama de Lima Sacht, Darcleia Souza Alves, Ranniely de Souza Caires, Nely Cristina Medeiros 2021-09-12T14:28:06Zoai:ojs.pkp.sfu.ca:article/18103Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:38:18.519017Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Dental care to patients using Biposphonates: Case report Atención Dental al paciente con Biposfonatos: Reporte de caso Atendimento Odontológico a paciente em uso de Bifosfonatos: Relato de caso |
title |
Dental care to patients using Biposphonates: Case report |
spellingShingle |
Dental care to patients using Biposphonates: Case report Amazonas, Elizama de Lima Osteoporose Bifosfonatos Osteonecrose Odontólogos. Osteoporosis Diphosphonates Osteonecrosis Dentists. Osteoporosis Bifosfonatos Osteonecrosis Odontologos. |
title_short |
Dental care to patients using Biposphonates: Case report |
title_full |
Dental care to patients using Biposphonates: Case report |
title_fullStr |
Dental care to patients using Biposphonates: Case report |
title_full_unstemmed |
Dental care to patients using Biposphonates: Case report |
title_sort |
Dental care to patients using Biposphonates: Case report |
author |
Amazonas, Elizama de Lima |
author_facet |
Amazonas, Elizama de Lima Sacht, Darcleia Souza Alves, Ranniely de Souza Caires, Nely Cristina Medeiros |
author_role |
author |
author2 |
Sacht, Darcleia Souza Alves, Ranniely de Souza Caires, Nely Cristina Medeiros |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Amazonas, Elizama de Lima Sacht, Darcleia Souza Alves, Ranniely de Souza Caires, Nely Cristina Medeiros |
dc.subject.por.fl_str_mv |
Osteoporose Bifosfonatos Osteonecrose Odontólogos. Osteoporosis Diphosphonates Osteonecrosis Dentists. Osteoporosis Bifosfonatos Osteonecrosis Odontologos. |
topic |
Osteoporose Bifosfonatos Osteonecrose Odontólogos. Osteoporosis Diphosphonates Osteonecrosis Dentists. Osteoporosis Bifosfonatos Osteonecrosis Odontologos. |
description |
Osteoporosis is a progressive systemic disease of the skeleton, characterized by reduced bone density and microstructure deterioration of bone tissue. For treatment, the use of bisphosphonates (BFFs) has been recommended as the first choice anti-resorptive therapy. The objective of this work is to describe, through a case report, a dental care protocol for a patient with Osteoporosis and using BFs. The work was submitted and approved by the Research Ethics Committee (CEP), opinion No.: 3.646.508/2019. Female patient, 30 years old, black, with osteoporosis, was referred for dental treatment. At the time of the Anamnesis, he reported using Alendronate Sodium 70mg/day. After clinical examination, laboratory tests for CTX-I dosage and radiographic evaluation, the suggested treatment plan was presented: clinical crown augmentation surgery and subsequent endodontic treatment and oral rehabilitation of tooth 25, which was promptly approved by the patient and signed the Informed Consent Term (TCLE). One week before the surgical procedure for clinical crown augmentation, the suspension of Alendronate sodium was requested. After the endodontic treatment, the prosthetic rehabilitation was carried out, restoring the masticatory and aesthetic function of the teeth, restoring the patient's self-esteem. It was concluded in the present study that it is possible to carry out the dental treatment of patients in bisphosphonate therapy safely, if a well-conducted and detailed anamnesis is carried out and safe treatment protocols are adopted, always aiming at the quality of life and patient satisfaction. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-07-24 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18103 10.33448/rsd-v10i9.18103 |
url |
https://rsdjournal.org/index.php/rsd/article/view/18103 |
identifier_str_mv |
10.33448/rsd-v10i9.18103 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18103/16084 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 9; e22810918103 Research, Society and Development; Vol. 10 Núm. 9; e22810918103 Research, Society and Development; v. 10 n. 9; e22810918103 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052787553468416 |